vs
欧加隆（OGN）与RENAISSANCERE HOLDINGS LTD（RNR）财务数据对比。点击上方公司名可切换其他公司
RENAISSANCERE HOLDINGS LTD的季度营收约是欧加隆的1.5倍（$2.2B vs $1.5B），RENAISSANCERE HOLDINGS LTD净利率更高（23.5% vs -13.6%，领先37.1%），欧加隆同比增速更快（-5.3% vs -36.8%），过去两年欧加隆的营收复合增速更高（-3.6% vs -11.9%）
欧加隆是一家总部位于美国新泽西州泽西城的制药企业，核心业务覆盖生殖医学、避孕、精神科、激素替代疗法及麻醉领域的药物研发与生产。公司所有产品均在美国境外生产，同时美国市场贡献了其三分之一的营收。
RenaissanceRe Holdings Ltd是总部位于百慕大的保险及相关商业服务提供商，核心业务覆盖再保险、常规保险两大板块，同时运营风险相关创新投资业务，为全球客户提供专业的风险对冲与保险解决方案。
OGN vs RNR — 直观对比
营收规模更大
RNR
是对方的1.5倍
$1.5B
营收增速更快
OGN
高出31.4%
-36.8%
净利率更高
RNR
高出37.1%
-13.6%
两年增速更快
OGN
近两年复合增速
-11.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $2.2B |
| 净利润 | $-205.0M | $515.8M |
| 毛利率 | 49.2% | — |
| 营业利润率 | -9.8% | — |
| 净利率 | -13.6% | 23.5% |
| 营收同比 | -5.3% | -36.8% |
| 净利润同比 | -288.1% | 72.6% |
| 每股收益（稀释后） | $-0.78 | $6.57 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OGNRNR
| Q1 26 | — | $2.2B | ||
| Q4 25 | $1.5B | $3.0B | ||
| Q3 25 | $1.6B | $3.2B | ||
| Q2 25 | $1.6B | $3.2B | ||
| Q1 25 | $1.5B | $3.5B | ||
| Q4 24 | $1.6B | $2.3B | ||
| Q3 24 | $1.6B | $4.0B | ||
| Q2 24 | $1.6B | $2.8B |
净利润OGNRNR
| Q1 26 | — | $515.8M | ||
| Q4 25 | $-205.0M | $760.5M | ||
| Q3 25 | $160.0M | $916.5M | ||
| Q2 25 | $145.0M | $835.4M | ||
| Q1 25 | $87.0M | $170.0M | ||
| Q4 24 | $109.0M | $-189.7M | ||
| Q3 24 | $359.0M | $1.2B | ||
| Q2 24 | $195.0M | $503.9M |
毛利率OGNRNR
| Q1 26 | — | — | ||
| Q4 25 | 49.2% | — | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 54.8% | — | ||
| Q1 25 | 55.6% | — | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 58.3% | — | ||
| Q2 24 | 58.4% | — |
营业利润率OGNRNR
| Q1 26 | — | — | ||
| Q4 25 | -9.8% | 42.5% | ||
| Q3 25 | 15.2% | 46.3% | ||
| Q2 25 | 14.4% | 41.8% | ||
| Q1 25 | 6.7% | -2.0% | ||
| Q4 24 | 8.1% | -3.6% | ||
| Q3 24 | 13.1% | 43.7% | ||
| Q2 24 | 14.6% | 25.0% |
净利率OGNRNR
| Q1 26 | — | 23.5% | ||
| Q4 25 | -13.6% | 25.6% | ||
| Q3 25 | 10.0% | 28.7% | ||
| Q2 25 | 9.1% | 26.1% | ||
| Q1 25 | 5.8% | 4.9% | ||
| Q4 24 | 6.8% | -8.3% | ||
| Q3 24 | 22.7% | 29.8% | ||
| Q2 24 | 12.1% | 17.8% |
每股收益（稀释后）OGNRNR
| Q1 26 | — | $6.57 | ||
| Q4 25 | $-0.78 | $16.16 | ||
| Q3 25 | $0.61 | $19.40 | ||
| Q2 25 | $0.56 | $17.20 | ||
| Q1 25 | $0.33 | $3.27 | ||
| Q4 24 | $0.42 | $-3.76 | ||
| Q3 24 | $1.38 | $22.62 | ||
| Q2 24 | $0.75 | $9.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $574.0M | $1.6B |
| 总债务越低越好 | $8.6B | — |
| 股东权益账面价值 | $752.0M | $4.3B |
| 总资产 | $12.9B | $53.7B |
| 负债/权益比越低杠杆越低 | 11.49× | — |
8季度趋势，按日历期对齐
现金及短期投资OGNRNR
| Q1 26 | — | $1.6B | ||
| Q4 25 | $574.0M | $1.7B | ||
| Q3 25 | $672.0M | $1.7B | ||
| Q2 25 | $599.0M | $1.4B | ||
| Q1 25 | $547.0M | $1.6B | ||
| Q4 24 | $675.0M | $1.7B | ||
| Q3 24 | $763.0M | $1.6B | ||
| Q2 24 | $704.0M | $1.6B |
总债务OGNRNR
| Q1 26 | — | — | ||
| Q4 25 | $8.6B | $2.3B | ||
| Q3 25 | $8.8B | $2.2B | ||
| Q2 25 | $8.9B | $2.3B | ||
| Q1 25 | $9.0B | $2.8B | ||
| Q4 24 | $8.9B | $1.9B | ||
| Q3 24 | $8.7B | $1.9B | ||
| Q2 24 | $8.7B | $2.0B |
股东权益OGNRNR
| Q1 26 | — | $4.3B | ||
| Q4 25 | $752.0M | $11.6B | ||
| Q3 25 | $906.0M | $11.5B | ||
| Q2 25 | $733.0M | $10.8B | ||
| Q1 25 | $542.0M | $10.3B | ||
| Q4 24 | $472.0M | $10.6B | ||
| Q3 24 | $493.0M | $11.2B | ||
| Q2 24 | $144.0M | $10.2B |
总资产OGNRNR
| Q1 26 | — | $53.7B | ||
| Q4 25 | $12.9B | $53.8B | ||
| Q3 25 | $13.6B | $54.5B | ||
| Q2 25 | $13.5B | $54.7B | ||
| Q1 25 | $13.2B | $53.6B | ||
| Q4 24 | $13.1B | $50.7B | ||
| Q3 24 | $12.8B | $52.8B | ||
| Q2 24 | $12.2B | $51.6B |
负债/权益比OGNRNR
| Q1 26 | — | — | ||
| Q4 25 | 11.49× | 0.20× | ||
| Q3 25 | 9.74× | 0.19× | ||
| Q2 25 | 12.14× | 0.21× | ||
| Q1 25 | 16.52× | 0.27× | ||
| Q4 24 | 18.81× | 0.18× | ||
| Q3 24 | 17.75× | 0.17× | ||
| Q2 24 | 60.11× | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $141.0M | — |
| 自由现金流经营现金流 - 资本支出 | $96.0M | — |
| 自由现金流率自由现金流/营收 | 6.4% | — |
| 资本支出强度资本支出/营收 | 3.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $538.0M | — |
8季度趋势，按日历期对齐
经营现金流OGNRNR
| Q1 26 | — | — | ||
| Q4 25 | $141.0M | $483.0M | ||
| Q3 25 | $264.0M | $1.6B | ||
| Q2 25 | $220.0M | $1.5B | ||
| Q1 25 | $75.0M | $157.8M | ||
| Q4 24 | $390.0M | $778.9M | ||
| Q3 24 | $141.0M | $1.5B | ||
| Q2 24 | $332.0M | $1.2B |
自由现金流OGNRNR
| Q1 26 | — | — | ||
| Q4 25 | $96.0M | — | ||
| Q3 25 | $218.0M | — | ||
| Q2 25 | $181.0M | — | ||
| Q1 25 | $43.0M | — | ||
| Q4 24 | $335.0M | — | ||
| Q3 24 | $99.0M | — | ||
| Q2 24 | $300.0M | — |
自由现金流率OGNRNR
| Q1 26 | — | — | ||
| Q4 25 | 6.4% | — | ||
| Q3 25 | 13.6% | — | ||
| Q2 25 | 11.4% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 21.0% | — | ||
| Q3 24 | 6.3% | — | ||
| Q2 24 | 18.7% | — |
资本支出强度OGNRNR
| Q1 26 | — | — | ||
| Q4 25 | 3.0% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 2.0% | — |
现金转化率OGNRNR
| Q1 26 | — | — | ||
| Q4 25 | — | 0.64× | ||
| Q3 25 | 1.65× | 1.73× | ||
| Q2 25 | 1.52× | 1.76× | ||
| Q1 25 | 0.86× | 0.93× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 0.39× | 1.26× | ||
| Q2 24 | 1.70× | 2.41× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
